SINOVAC BIOTECH LTD Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
SINOVAC BIOTECH LTD (SVA) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals of $83.31 million as of 2023-12-31, per its 20-F filed 2024-04-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals · last filed 2024-04-29
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $83.31M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $64.28M.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $56.31M.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $17.24M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals as first filed |
|---|---|---|
| 2023-12-31 | $83.31M 20-F · filed 2024-04-29 | |
| 2022-12-31 | $64.28M 20-F · filed 2024-04-29 | |
| 2021-12-31 | $56.31M 20-F · filed 2023-05-01 | |
| 2020-12-31 | $17.24M 20-F · filed 2022-04-29 | |
| 2019-12-31 | $4.18M 20-F · filed 2021-04-22 | |
| 2018-12-31 | $3.76M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $8.48M 20-F · filed 2019-04-29 | |
| 2016-12-31 | $3.12M 20-F · filed 2018-05-11 | |
| 2015-12-31 | $2.55M 20-F · filed 2017-11-22 | |
| 2014-12-31 | $2.41M 20-F · filed 2016-04-25 | $2.41M 20-F · filed 2015-04-29 |
| 2013-12-31 | $1.98M 20-F · filed 2015-04-29 | |
| 2012-12-31 | $1.74M 20-F · filed 2014-04-16 |